Ocular Therapeutix Inc $OCUL

Recent News (4)

• Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs Yahoo Finance · 03 Sep 2026 Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs
• Ocular Therapeutix stock rises as rival’s wet AMD trial stumbles By Investing.com Investing.com South Africa · 17 Aug 2026 Ocular Therapeutix stock rises as rival’s wet AMD trial stumbles By Investing.com  Investing.com South Africa
• Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · 13 Aug 2026 BEDFORD, Mass., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to redefining the retina exper…
• Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights GlobeNewswire · 03 Aug 2026 Ocular’s AXPAXLITM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026